中文 | English
Return
Total: 8 , 1/1
Show Home Prev Next End page: GO
Author:( Zhaofeng LIANG)

1.Coagulation disorders are associated with severity of sepsis in infected patients admitted toemergency department

Wei ZHANG ; Zhaofeng LIN ; Jinlong QU ; Liang CHANG

Chinese Journal of Emergency Medicine 2012;21(2):123-127

2.Vinorelbine and Nedaplatin Regimen in Treatment of Advanced Non-small Cell lung Cancer

Yongzhong LIU ; Jiewen PENG ; Zhaofeng YIN ; Hanlin LIANG

Journal of Medical Research 2006;0(06):-

3.Comparison of Transdermal Penetration of Two New Kinds of Triamcinolone Acetonide Lipid Carriers

Guoqiang WANG ; Zhaofeng LIANG ; Junfeng BAN ; Guanghan DENG ; Jiacheng LIN ; Zhufen LYU

Herald of Medicine 2015;(3):361-365

4.Effect of ICE regimen in treatment of relapsed and refractory non-Hodgkin's lymphoma

Yongzhong LIU ; Shuyi HANG ; Jiewen PENG ; Jinghuang HE ; Hanlin LIANG ; Zhaofeng YIN

Chinese Journal of Primary Medicine and Pharmacy 2011;18(18):2479-2480

5.Experimental study of bioabsorbable iron-based pulmonary artery stent

Dongpo LIANG ; Zhiwei ZHANG ; Shushui WANG ; Xu ZHANG ; Zhaofeng XIE ; Guohong ZENG

Chinese Journal of Applied Clinical Pediatrics 2014;29(6):459-463

6.Expression of lncRNA RN7SK in tissue samples from gastric cancer patients and its screening diagnostic value

Xia LI ; Zhaofeng LIANG ; Jiahui MAO ; Rongrong WANG ; Hui QIAN ; Wenrong XU

Chinese Journal of Clinical Laboratory Science 2018;36(5):342-344

7.Emodin Inhibits Doxorubicin-Induced Cardiotoxicity by Regulating miR-29a-5p/VEGFB Mediated Apoptosis

Zhaofeng ZHANG ; Ruohan TANG ; Liang ZHANG

World Science and Technology-Modernization of Traditional Chinese Medicine 2023;25(6):2025-2035

8.Exosomes in bladder cancer: novel biomarkers and targets.

Hao GENG ; Qingchen ZHOU ; Wenhao GUO ; Ling LU ; Liangkuan BI ; Yi WANG ; Jie MIN ; Dexin YU ; Zhaofeng LIANG

Journal of Zhejiang University. Science. B 2021;22(5):341-347

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 8 , 1/1 Show Home Prev Next End page: GO